We recently found increased microglial activation in the brain of the Cdkl5 KO mouse [43]; indeed, modulation of microglial activation seems to be a therapeutic approach to be considered for CDD. The gene discussed is CDKL5; the disease is craniodiaphyseal dysplasia.